Delivery Order SPE2DB22D3301-SPE2DB24FZ2SG

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dexmedetomidine 200 mcg/2 ml injection. The contract has a ceiling value of $9,615.22 and an ultimate completion date of December 7, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
This federal contract award, valued at $14,711.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a medication used in medical settings. The award, which does not have a set-aside designation, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
The federal contract award is for the delivery of 4563422255 DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,637.87 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,906.46, is for the supply of Dexmedetomidine 400mcg/100ml-NS 100ml, a medication used for sedation. The award is not set-aside and is a firm fixed-price contract. It has an ultimate completion date of June 6, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,117.21, is for the delivery of DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a specialty medication. This appears to be a firm-fixed-price delivery order contract without any set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order, valued at $2,705.43, is for the supply of the pharmaceutical product Dexmedetomidine 400mcg/100ml-NS 100ml. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a period of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMEDETOMIDIN 400MCG/100ML-NS 100ML, a medical supply product, with a ceiling value of $2,093.78. The contract is a firm fixed price type, has an ultimate completion date of May 20, 2025, and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,508.40, is a delivery order for a medical product described as "DEXTR-AMP ER 10MG 100S". The contract is a firm fixed-price arrangement with a completion date of February 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
The Defense Logistics Agency awarded a $979 delivery order to Amerisourcebergen Drug Corporation for Dexmedetomidine 200 mcg/2ml vials. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the DLA under a firm fixed price contract executed from August 24-25, 2023. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were identified. The DLA manages the global supply chain for...
This federal contract award, valued at $3,476.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2SG
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of dexmedetomidine 200 mcg/2 ml vials. The award, valued at $3,889.83, has a firm-fixed-price contract type and an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/11/24, 9:28 AM